TY  - GEN
AU  - Rowe,Jacob M
TI  - Progress and predictions: AML in 2018
SN  - 1532-1924
PY  - 2019///0620
KW  - Drug Approval
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Isocitrate Dehydrogenase
KW  - antagonists & inhibitors
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Neoplasm, Residual
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - United States
KW  - United States Food and Drug Administration
KW  - fms-Like Tyrosine Kinase 3
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.beha.2018.09.002
ER  -